Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Leukemia Research
|
February 1, 1997
P53 protein expression in human multidrug-resistant CEM lymphoblasts
N Rafki, F Liautaud-Roger, L Devy, et al.
Biochemical Pharmacology
|
March 22, 1996
Evidence for distinct regulation processes in the aclacinomycin- and doxorubicin-mediated differentiation of human erythroleukemic cells
F Morceau, A Aries, R Lahlil, et al.
Therapie
|
January 25, 2002
[Role of plasminogen activator inhibitor type 1 in tumor angiogenesis]
K Bajou, L Devy, V Masson, et al.
Leukemia & Lymphoma
|
August 1, 1997
Anthracyclines as tumor cell differentiating agents: effects on the regulation of erythroid gene expression
P Jeannesson, R Lahlil, B Chenais, et al.
Angiogenesis
|
January 25, 2002
Improved quantification of angiogenesis in the rat aortic ring assay
S Blacher, L Devy, M F Burbridge, et al.
Experimental Cell Research
|
May 23, 1998
Induction of endothelial cell apoptosis by solid tumor cells
F Kebers, J M Lewalle, J Desreux, et al.
Biochemical and Biophysical Research Communications
|
October 23, 1997
Production and activation of matrix metalloprotease-9 (MMP-9) by HL-60 promyelocytic leukemia cells
L Devy, A Noël, E Baramova, et al.
Cellular and Molecular Life Sciences : CMLS
|
May 10, 2003
Role of plasminogen activator-plasmin system in tumor angiogenesis
J M Rakic, C Maillard, M Jost, et al.
Invasion & Metastasis
|
January 1, 1997
Emerging roles for proteinases in cancer
A Noël, C Gilles, K Bajou, et al.
Surgical Oncology Clinics of North America
|
May 31, 2001
New functions of stromal proteases and their inhibitors in tumor progression
A Noel, V Albert, K Bajou, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Leukemia Research
|
February 1, 1997
P53 protein expression in human multidrug-resistant CEM lymphoblasts
N Rafki, F Liautaud-Roger, L Devy, et al.
Biochemical Pharmacology
|
March 22, 1996
Evidence for distinct regulation processes in the aclacinomycin- and doxorubicin-mediated differentiation of human erythroleukemic cells
F Morceau, A Aries, R Lahlil, et al.
Therapie
|
January 25, 2002
[Role of plasminogen activator inhibitor type 1 in tumor angiogenesis]
K Bajou, L Devy, V Masson, et al.
Leukemia & Lymphoma
|
August 1, 1997
Anthracyclines as tumor cell differentiating agents: effects on the regulation of erythroid gene expression
P Jeannesson, R Lahlil, B Chenais, et al.
Angiogenesis
|
January 25, 2002
Improved quantification of angiogenesis in the rat aortic ring assay
S Blacher, L Devy, M F Burbridge, et al.
Experimental Cell Research
|
May 23, 1998
Induction of endothelial cell apoptosis by solid tumor cells
F Kebers, J M Lewalle, J Desreux, et al.
Biochemical and Biophysical Research Communications
|
October 23, 1997
Production and activation of matrix metalloprotease-9 (MMP-9) by HL-60 promyelocytic leukemia cells
L Devy, A Noël, E Baramova, et al.
Cellular and Molecular Life Sciences : CMLS
|
May 10, 2003
Role of plasminogen activator-plasmin system in tumor angiogenesis
J M Rakic, C Maillard, M Jost, et al.
Invasion & Metastasis
|
January 1, 1997
Emerging roles for proteinases in cancer
A Noël, C Gilles, K Bajou, et al.
Surgical Oncology Clinics of North America
|
May 31, 2001
New functions of stromal proteases and their inhibitors in tumor progression
A Noel, V Albert, K Bajou, et al.
Page
of 2